Share
 
Title
Code
Session Type
Track
Format
CME accreditation
ROOM/CHANNEL
Date Time
Moderators

Development and availability of medical devices and therapeutics have been rapidly evolving. The COVID-19 pandemic serves as a reminder that strategies and policies must be in place to ensure equitable access to new products. This session will discuss innovative strategies, collaborative partnerships and transparent processes to identify relevant stakeholders. Active engagement of treatment access advocates, government agencies, policy makers, government and non-governmental funders, regulatory bodies and pharmaceutical companies is key to achieving rapid and effective health product roll out in low- and middle-income countries.

14:15
2 min
Introduction
Vuyiseka DUBULA MAJOLA, Africa Centre for HIV/AIDS Management, South Africa
Jürgen ROCKSTROH, University of Bonn, Germany
14:17
8 min
Strategies to enhance equitable health product roll out in low- and middle-income countries
Esteban BURRONE, Medicines Patent Pool, France
14:25
8 min
Collaborative and innovative approaches to novel health product introduction
Mitchell WARREN, AVAC, United States
14:33
8 min
Use of research and partnerships to inform access strategies
Karin HATZOLD, Population Services International, South Africa
14:41
34 min
Q&A
Jürgen ROCKSTROH, University of Bonn, Germany
Esteban BURRONE, Medicines Patent Pool, France
Vuyiseka DUBULA MAJOLA, Africa Centre for HIV/AIDS Management, South Africa
Mitchell WARREN, AVAC, United States
Karin HATZOLD, Population Services International, South Africa
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT